These vesicles harness PSGL-1 to target damaged endothelial cells, releasing IL-37 to stimulate endothelial proliferation, angiogenesis, and prevent inflammatory cell infiltration, thus alleviating AKI [282]. Here, IL37 is linked to acute kidney injury.